Amantadine Hydrochloride is a dual-mechanism agent that blocks the influenza A M2 ion channel and modulates dopaminergic and glutamatergic transmission, giving it use both as an antiviral and as an adjunct therapy in Parkinson's disease. Simson Pharma's reference standard and impurities support compendial testing across both of these distinct therapeutic applications.

Simson Pharma Global Ltd. (UK) and Simson Pharma Global LLC (USA) supply high-quality Amantadine Hydrochloride Reference Standards, pharmacopoeial reference materials, and its related impurities to pharmaceutical manufacturers, CROs, analytical laboratories, universities, and regulatory organizations worldwide. To service the Europe and America market efficiently, Simson Pharma Limited has set up Simson Pharma Global Ltd. in United Kingdom and Simson Pharma Global LLC in USA respectively.